Mitotane, sold under the brand name Lysodren, is a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used in the treatment of adrenocortical carcinoma and Cushing’s syndrome.
| Product Name: | Mitotane/Mitotan |
| Synonyms: | LYSODREN;2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)-1,1-DICHLOROETHANE;2,2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane;2,4′-TDE;2,4′-DDD;(2,4′-DICHLORODIPHENYL)DICHLOROETHANE;1,1-DICHLORO-2-(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)ETHANE;1,1-DICHLORO-2-(2-CHLOROPHENYL)-2-(4-CHLOROPHENYL)ETHANE |
| CAS: | 53-19-0 |
| MF: | C14H10Cl4 |
| MW: | 320.04 |
| EINECS: | 200-166-6 |